IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q4 2024 Holdings

Filed 2025-02-14 | 15 holdings | $66.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$13.3M707,58920.1%
Blueprint Medicines Corp(2L9)COM09627Y109$11.3M129,60017.0%
Kymera Therapeutics Inc(KYMR)COM501575104$7.4M183,52111.1%
Amgen Inc(AMGN)CallCOM031162100$6.5M25,0009.8%
Arvinas Inc(ARVN)COM04335A105$6.3M328,7669.5%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$3.1M221,9114.7%
Protagonist Therapeutics Inc(PTGX)COM74366E102$3.0M76,5924.5%
Regenxbio Inc(RGNX)COM75901B107$2.7M346,3024.0%
Immatics N.v(IMTX)SHSN44445109$2.7M373,9024.0%
Silence Therapeutics PLC(SLN)ADS82686Q101$2.5M367,2143.8%
Adicet BIO Inc(TORCEUR)COM007002108$2.4M2,531,1943.7%
Precision Biosciences Inc(DTIL)COM NEW74019P207$2.0M536,3763.1%
Repare Therapeutics Inc(RPTX)COM760273102$1.7M1,293,7152.6%
Arrowhead Pharmaceuticals in(ARWR)CallCOM04280A100$1.4M75,0002.1%
Sutro Biopharma IncCOM869367102$9164980.0%